Actively Recruiting
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
Led by Northwell Health · Updated on 2024-09-19
300
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
Sponsors
N
Northwell Health
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying patients experiencing their first episode of psychosis who are receiving coordinated specialty care (CSC). The study aims to identify those at high risk of disengaging from treatment and to test ways to prevent or delay this from happening. Maintaining engagement is important for patients to benefit fully from CSC, and this research focuses on improving that outcome. The study has two phases. In Phase 1, researchers will confirm a model that predicts which patients might later disengage from care. In Phase 2, participants identified as high risk will be randomly assigned to receive either a special Step-down intervention using web-based telemedicine and a smartphone app or the usual care provided by the CSC center. This intervention is designed to reduce the chance of disengagement. Participants will be monitored to see how often they stay engaged in care over at least six months. Researchers will measure the rate of disengagement between the two groups. The study will include assessments through telemedicine and app use, with ongoing follow-up to evaluate the effectiveness of the intervention in keeping patients connected with their care team. The total participation duration varies based on individual involvement in the study phases.
CONDITIONS
Brief Title
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Enrolled into a CSC program
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At least 6 months
Participants receive either the CSC Step-down intervention involving web-based telemedicine and a smartphone app, or usual care provided by the CSC center to reduce disengagement likelihood.
Regular contacts via telemedicine or in-person visits depending on assigned group
Trial Site Locations
Total: 3 locations
1
Henderson Behavioral Health
Lauderdale Lakes, Florida, United States, 33319
Actively Recruiting
2
InterAct of Michigan
Grand Rapids, Michigan, United States, 49503
Actively Recruiting
3
InterAct of Michigan
Kalamazoo, Michigan, United States, 49007
Actively Recruiting
Research Team
P
Patricia Marcy, BSN
C
Cristina Gonzalez, MS
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here